|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4155 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 17/04 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 4333840 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22725046.1 |
| Date of filing the European patent application | 2022-05-03 | |
| (97) | Date of publication of the European application | 2024-03-13 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-05 |
| (46) | Date of publication of the claims translation | 2026-01-12 |
| (86) | Number | PCT/US2022/027389 |
| Date | 2022-05-03 |
| (87) | Number | WO 2022/235613 |
| Date | 2022-11-10 |
| (30) | Number | Date | Country code |
| 202163183249 P | 2021-05-03 | US |
| (72) |
SMITH, Paul , US
BROWN, Kurt Andrew , US
|
| (73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | JAK1 kelio inhibitoriai, skirti mazgelinio niežulio gydymui |
| JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARIS |